Literature DB >> 24650927

TCTP as therapeutic target in cancers.

Julie Acunzo1, Virginie Baylot1, Alan So2, Palma Rocchi3.   

Abstract

The translationally controlled tumor protein (TCTP) is a highly conserved protein present in eukaryotic organisms. This protein, located both in the cytoplasmic and the nucleus, is expressed in various tissues and is regulated in response to a wide range of extracellular stimuli. TCTP interacts with itself and other protein including MCL1 and p53. TCTP has been shown to play an important role in physiological events, such as cell proliferation, cell death and immune responses but also in stress response and tumor reversion. Moreover, TCTP expression is associated with malignancy and chemoresistance. In this review, we will evaluate pathways regulated by TCTP and current inhibitory strategy to target TCTP in cancerous diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Inhibitory strategy; TCTP; Therapeutic target

Mesh:

Substances:

Year:  2014        PMID: 24650927     DOI: 10.1016/j.ctrv.2014.02.007

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  36 in total

1.  High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas.

Authors:  Pramila Ramani; Rachel Nash; Emile Sowa-Avugrah; Chris Rogers
Journal:  J Neurooncol       Date:  2015-08-29       Impact factor: 4.130

2.  Conserved abundance and topological features in chromatin-remodeling protein interaction networks.

Authors:  Mihaela E Sardiu; Joshua M Gilmore; Brad D Groppe; Damir Herman; Sreenivasa R Ramisetty; Yong Cai; Jingji Jin; Ronald C Conaway; Joan W Conaway; Laurence Florens; Michael P Washburn
Journal:  EMBO Rep       Date:  2014-11-26       Impact factor: 8.807

3.  Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing.

Authors:  Chao Chen; Paola Posocco; Xiaoxuan Liu; Qiang Cheng; Erik Laurini; Jiehua Zhou; Cheng Liu; Yang Wang; Jingjie Tang; Valentina Dal Col; Tianzhu Yu; Suzanne Giorgio; Maurizio Fermeglia; Fanqi Qu; Zicai Liang; John J Rossi; Minghua Liu; Palma Rocchi; Sabrina Pricl; Ling Peng
Journal:  Small       Date:  2016-05-31       Impact factor: 13.281

Review 4.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

5.  Comparative proteomics analysis of global cellular stress responses to hydroxyurea-induced DNA damage in HeLa cells.

Authors:  Chao You; Yanhua Yang; Lei Zhang; Huiqing Chen; Yan Chen; Keping Chen; Yajing Zhou
Journal:  Cytotechnology       Date:  2014-12-18       Impact factor: 2.058

Review 6.  Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.

Authors:  Junying Gao; Yan Ma; Guiwen Yang; Guorong Li
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

7.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

8.  A Potential Role for Exosomal Translationally Controlled Tumor Protein Export in Vascular Remodeling in Pulmonary Arterial Hypertension.

Authors:  Elisabet Ferrer; Benjamin J Dunmore; Dhiya Hassan; Mark L Ormiston; Stephen Moore; John Deighton; Lu Long; Xu Dong Yang; Duncan J Stewart; Nicholas W Morrell
Journal:  Am J Respir Cell Mol Biol       Date:  2018-10       Impact factor: 6.914

9.  A novel ligand of the translationally controlled tumor protein (TCTP) identified by virtual drug screening for cancer differentiation therapy.

Authors:  Nicolas Fischer; Ean-Jeong Seo; Sara Abdelfatah; Edmond Fleischer; Anette Klinger; Thomas Efferth
Journal:  Invest New Drugs       Date:  2021-01-25       Impact factor: 3.850

10.  Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.

Authors:  Philipp Kolb; Reinhard Wallich; Michael Nassal
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.